Emgality

Galcanezumab-Gnlm

7.4 High risk

Emgality & Injection site pain

17.3%

of users reported Injection site pain

53.6%

also reported Hospitalization

91.8%

are women

Most common medical consequences

Hospitalization
53.6%
Severe reaction
39.3%
Disability
3.6%
Medical Intervention
3.6%

Have you experienced any negative side effects from this medication?

Emgality: general information

Most common side effects (191)

Most commonly affected ages

10 - 19 years
1.8%
20 - 29 years
12.0%
30 - 39 years
18.3%
40 - 49 years
24.1%
50 - 59 years
24.1%
60 - 69 years
14.5%
70 - 79 years
4.9%
80 - 89 years
0.3%